Seek Labs

Seek Labs

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://seeklabs.com

Last Round

Series B

Aug 18, 2023

Total Funding Raised

$13.6M

Company Overview

Seek Labs is a biotechnology company that develops next-generation molecular diagnostic systems and pharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

molecular diagnosticsCRISPR therapeuticsAI discovery enginepoint-of-care diagnosticsinstrument-free diagnosticsdecentralized diagnosticsportable molecular testingdrug discovery AIanimal healthpandemic readinessbiosecurityveterinary diagnosticsmedical countermeasuressynthetic biologytechnology licensinggenetic target identification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seek Labs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Seek Labs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BAug 18, 2023

Key People

Founding team and executive leadership

Brad Bauer

Chief Technology Officer

Executive Team

Seek Labs Investors

Notable investors and investment history

InvestorRounds
Weobly One CapitalSeries B
HomeStake Venture PartnersSeries B
UVB CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2026

    Developing a CRISPR-based therapeutic to combat avian flu.

  • Feb 17, 2026

    Partnering with Canadian Food Inspection Agency on avian flu therapeutic.

Seek Labs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Seek Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Seek Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range35
Year Founded2016
Last FundingAug 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.